American Well (AMWL) Set to Announce Quarterly Earnings on Wednesday

American Well (NYSE:AMWLGet Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of ($3.32) per share for the quarter. American Well has set its FY 2024 guidance at EPS.Investors interested in listening to the company’s conference call can do so using this link.

American Well (NYSE:AMWLGet Free Report) last released its earnings results on Wednesday, July 31st. The company reported ($3.36) earnings per share for the quarter, beating analysts’ consensus estimates of ($3.94) by $0.58. The firm had revenue of $62.79 million during the quarter, compared to the consensus estimate of $60.78 million. American Well had a negative net margin of 120.44% and a negative return on equity of 50.36%. During the same period in the prior year, the firm earned ($4.60) EPS. On average, analysts expect American Well to post $-13 EPS for the current fiscal year and $-8 EPS for the next fiscal year.

American Well Trading Down 0.8 %

AMWL opened at $10.09 on Wednesday. The company has a 50 day moving average of $9.17 and a 200 day moving average of $9.08. The company has a market cap of $149.56 million, a PE ratio of -0.41 and a beta of 1.05. American Well has a 12 month low of $5.00 and a 12 month high of $31.60.

Analysts Set New Price Targets

Several research firms recently commented on AMWL. Wells Fargo & Company cut their price objective on shares of American Well from $40.00 to $15.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a report on Tuesday, September 24th.

Get Our Latest Analysis on American Well

Insider Buying and Selling at American Well

In other American Well news, insider Kathy Johnson Weiler sold 7,266 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.87, for a total value of $57,183.42. Following the completion of the transaction, the insider now directly owns 188,027 shares of the company’s stock, valued at $1,479,772.49. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, CFO Robert Shepardson sold 5,177 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.87, for a total transaction of $40,742.99. Following the sale, the chief financial officer now owns 112,992 shares in the company, valued at approximately $889,247.04. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Kathy Johnson Weiler sold 7,266 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.87, for a total transaction of $57,183.42. Following the sale, the insider now owns 188,027 shares in the company, valued at approximately $1,479,772.49. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,141 shares of company stock valued at $178,729 in the last three months. Company insiders own 12.80% of the company’s stock.

American Well Company Profile

(Get Free Report)

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.

Further Reading

Earnings History for American Well (NYSE:AMWL)

Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.